Retinoblastoma is one of the most common childhood cancer tumours. It can be treated particularly well, provided it is diagnosed in time. However, the visual prognosis can be compromised depending on the location of the tumour and the impact of treatment on the retina.


Supported project

In 2020, L'OCCITANE Manosque and the Foundation are supporting the Institut Curie in its project to combat retinoblastoma in children. 

The project aims to create preclinical models of ocular tumors (retinoblastoma and uveal melanoma) on rats. Before moving on to clinical trials on humans, preclinical animal models are needed to test new treatments. The rat is a good model in ophthalmology research as its eyes are large enough to perform transplants of tumor cells from patients. The creation of two preclinical models of retinoblastoma and uveal melanoma will make it possible to test new treatments with the aim of maintaining the patient's eye as well as maximum visual acuity.

Some figures


Budget 10 000 euros

Goal 155 beneficiaries


Project supported since 2018

L'OCCITANE Manosque and the Foundation have supported the Institut Curie in its project to combat retinoblastoma in children since 2018.

In 2019, the supported project aimed to finance the purchase of a wide-angle camera in order to take photographs of the fundus of the eyes of children suffering from this pathology. These photographs madeit possible to complete the ophthalmological check-up of the patient and to maintain scientific research on retinoblastoma.  These documents wereextremely useful for patient follow-up and to perceive the tumor regression of the eye concerned. 

Budget 30 000 euros

Objectif 6 725 beneficiaries